Torley Helen bought HALO
February 9, 2026 · Form 4 insider transaction
Torley Helen bought 50,013 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,013
Price
$0.00
Total value
N/A
InsiderTorley Helen
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after50,013
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.